The phase 2 Early Vitrectomy and Intravitreal Antibiotics for Post-Operative Exogenous Endophthalmitis study showed that performing early vitrectomy for acute endophthalmitis can offer better and faster visual outcomes than the current treatment of prescribing antibiotics first.
Susvimo works in conjunction with the company’s port delivery platform, Contivue, which was specifically engineered for use with Susvimo.
Why AI-driven functional imaging could change how clinicians assess and treat retinal disease
PRIMA, the first brain-computer interface approved for form vision restoration (reading letters, numbers, words) in patients with geographic atrophy (GA) secondary to age-related macular degeneration, is commercially available in Europe.
David E. I. Pyott, CBE, MD(Hon), MBA, MA, discusses expanding subspecialty training and internationally recognized credentials in underserved regions.
A 10-year analysis finds latanoprost accounts for 40% of glaucoma prescriptions in New Zealand.
The long-term outcomes after primary scleral buckling procedures for rhegmatogenous retinal detachments showed high anatomic success, improved vision, and a good safety profile.
Antineoplastics were the most frequently implicated drug class in review
Real-world data support EndoArt as donor-independent option in high-risk patients
Andy Chang and Mikhail Boukhny of BVI Medical discuss the company's new Experience Hub in Sant Cugat, Spain, a hands-on training facility built to gather surgeon feedback ahead of the Virtuoso platform's European launch.
Biologic therapies linked to high remission rates over 2-year follow-up
Researchers identify microbial shifts tied to corneal disease history
Deeper anterior chamber depth and shorter disease course predicted better surgical outcomes
Ectoine eye drops boost tear stability and ease redness and tired eyes, along with burning, foreign body and dryness sensations, offering fast, irritation-free relief for patients with dry eye disease.
The US FDA approves Lumvoa for TED in active or chronic stages, showing rapid proptosis and diplopia improvements; safety monitoring includes hearing, hyperglycemia and infusion reactions.
Real-world data show dexamethasone intravitreal implant improves vision and thickness in RVO macular edema, with earlier anti-VEGF switching yielding better gains.
Charlie Zhang, MD, reflects on the rising incidence, diagnostic challenges and multidisciplinary management of immune checkpoint inhibitor–associated uveitis
Piotr Woźniak, MD, PhD, shares real-world evidence on Artelac Complete in dry eye disease from EuDEC 2026 in Milan, Italy, including improvements in tear break-up time and Schirmer scores, perioperative and contact lens use patterns, and high eye care practitioner satisfaction.
Researchers assessed accommodative changes after foldable iris-fixated phakic IOL implantation for myopic astigmatism
AI models predicting retinal function from OCT could transform geographic atrophy assessment in clinical care and trials
This is a promotional supplement commissioned by Roche Products Limited.
Two cases highlight the diagnostic challenges of Demodex blepharitis and underscore the unmet need for approved targeted therapies in the United Kingdom.
Utilize oral agents, diet and glucose monitoring systems when acting to preserve vision
A scoping review finds limited evidence on transition programmes for adolescents moving from paediatric to adult ophthalmology care
A sutureless amniotic membrane matrix achieved faster healing and lower costs than standard PED care in a two-centre NHS audit.
A retrospective study of 114 oculoplastic surgery patients found trehalose added to sodium hyaluronate improved tear break-up time, corneal staining, and meibomian gland loss compared with sodium hyaluronate alone, particularly after eyelid reconstruction.
The CE-marked lens is being placed by selected surgeons across 6 European countries under a company-described early-access program
New pathways are reshaping the management of retinal disease
Immediate flushing of the eye can significantly reduce long-term damage after chemical exposure
After accounting for key factors like eye length, researchers found no meaningful differences in corneal biomechanics between primary open-angle and primary angle-closure glaucoma.
